Infliximab-induced psoriasis in a patient with crohn′s disease

Abstract

Infliximab is a well-known treatment for inflammatory bowel diseases (IBDs) and psoriasis. Paradoxically, there have been numerous reports of new-onset psoriasis following tumor necrosis factor-α antagonist therapy in patients with IBD. Here, we report a case with Crohn′s disease who developed Infliximab-induced plaque-type psoriasis 4 months after initiation of treatment with Infliximab.

Keywords

• Biological therapy
• Crohn′s disease
• Infliximab
• psoriasis
• tumor necrosis factor-alpha inhibitors